Navigation Links
Sinobiopharma, Inc. Appoints New Director of Marketing
Date:4/8/2009

NANTONG, China, April 8 /PRNewswire-FirstCall/ -- Sinobiopharma Pharmaceutical Group (OTC Bulletin Board: SNBP) is pleased to announce the appointment of Ms. Yan Tan as Director of Marketing.

Ms. Tan joins Sinobiopharma from Organon Pharmaceutical Co., Ltd., Netherlands. She served as a China-based Unit Marketing Director for Organon, which was recently sold to Schering-Plough. Prior to Organon, Ms. Tan held senior marketing management roles at China National Medicines Corporation Ltd.

"We are delighted to welcome Ms. Tan to our team," said Lequn Huang, Chairman and CEO of Sinobiopharma. "Ms. Tan's valuable experience in marketing and sales from global healthcare and consumer businesses will bring additional marketing expertise to the company's sales and marketing strategy. I am confident that she will help us grow our business both domestically and internationally with specific initial focus on increasing sales to hospitals and pharmacies across China."

About Sinobiopharma

Sinobiopharma, Inc. is a fully integrated and highly innovative biotechnology company engaged in the research and development, manufacture and marketing of biopharmaceutical products in China, the world's fastest growing pharmaceutical market. Known as Dong Ying (Jiangsu) Pharmaceutical Co., Ltd. in China, the Company's current therapeutic focus is on anesthesia-assisted agents and cardiovascular drugs.

FORWARD LOOKING STATEMENTS

This news release may include "forward-looking statements" regarding Sinobiopharma, Inc., and its subsidiaries, business and project plans. Such forward looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor created by such sections. Where Sinobiopharma, Inc. expresses or impli
'/>"/>

SOURCE Sinobiopharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. Codexis Appoints Singapore Laboratories Managing Director
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
6. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
9. NeurogesX Appoints New Director to the Board
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... PARK, Calif. , July 24, 2014 /PRNewswire/ ... company in the emerging field of regenerative medicine, ... webcast of a presentation to investors on Tuesday, ... p.m. PDT.  The presentation will include an overview ... To access the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics ...
(Date:7/24/2014)... computers have yet to materialise. Yet, scientists are ... such computers faster. One such approach relies on ... by applying an electric field. A new study ... coupled quantum dots (TQDs) with electrical impulses can ... example, should TQDs be used as quantum information ...
(Date:7/24/2014)... 24, 2014 Research and Markets ... and Proteomics Analytical Instruments Market 2014-2018" report to ... Genomics is the study of the gene ... the structure and functions of proteomes or sets of ... technology. Genomics involves the mapping of genes and DNA ...
(Date:7/24/2014)... July 24, 2014 Three companies from ... in Livestrong’s Big C Competition. Out of 700 competition ... headed to the semi-final round. In this round twenty ... accelerator program, complete with mentoring from thought-leaders and medical ... part of the angelMD commitment to the Livestrong vision ...
Breaking Biology Technology:Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 23 angelMD Startups Make Livestrong Big C Semi-finals 2
... Angiotech Pharmaceuticals, Inc. ("Angiotech") (NASDAQ: ANPI , ... meeting of shareholders will take place on June 4, ... Grand Vancouver, 403 Robson Street, Vancouver, BC V6B 6L9. ... of and vote at the meeting will be April ...
... be invested in the first phase of this personalized ... National Functional Genomics Center , funded ... by the U.S. Army Medical Research & ... Telemedicine & Advanced Technology Research Center (TATRC), ...
... SILVER SPRING, Md., April 24 United Therapeutics Corporation ... will release its 2009 first quarter financial results before ... host a half-hour teleconference on Friday, May 1, 2009, ... accessible by dialing 877-718-5092, with international callers dialing 719-325-4795. ...
Cached Biology Technology:NFGC Conducts Multi-Institutional Research Project in Ovarian Cancer 2NFGC Conducts Multi-Institutional Research Project in Ovarian Cancer 3
(Date:7/25/2014)... Boston, MA A study published online in the ... describes a novel approach to preventing cervical cancer based ... cervical cancer after removal of a discrete population of ... from a study that looked at squamocolumnar junction cells, ... canal and have been implicated as the origins of ...
(Date:7/25/2014)... characterized by the existence of numerous isoforms arising ... the protein deeply different characteristics. NRG1 plays an ... development and the different phases occurring after injury ... remyelination and target reinnervation, Researchers at the University ... NRG1 upregulation observed in Schwann cells immediately after ...
(Date:7/25/2014)... use of a molecular testing panel developed at ... correct initial surgery for patients with thyroid nodules ... Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter., ... Center and other diagnostic testing agencies, improved the ... by 30 percent, according to the study published ...
Breaking Biology News(10 mins):Clearing cells to prevent cervical cancer 2Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3
... A major international study with leadership from Massachusetts General ... associated with blood sugar or insulin levels. Two ... associated with glucose levels were also found to increase ... a related study from members of the same research ...
... a team of researchers is releasing data today that it ... the family of parasites that causes a deadly trio of ... nations for centuries. In an article to be published ... , Vanderbilt University scientist Galina Lepesheva and her team are ...
... A breakthrough discovery by scientists at the University of Kentucky ... diseases of the brain, spinal cord and the eye. ... visual science in the UK College of Medicine, found that ... proteins vimentin and glial fibrillary acidic protein (GFAP) ...
Cached Biology News:New gene variants associated with glucose, insulin levels, some with diabetes risk 2Scientists hope to end sleeping sickness by making parasite that causes it self-destruct 2Scientists hope to end sleeping sickness by making parasite that causes it self-destruct 3Kentucky study advances new target for CNS drug development 2
Human Aminopeptidase P1/XPNPEP1 Affinity Purified PAb Protein Family: Aminopeptidases, Metalloproteases...
Template and primers for preparation of internal control spots...
Cross reactivity to St. Louis encephalitis (MSI-7) is determined by ELISA....
...
Biology Products: